Are We Moving Towards Development of Universal Drug Regimen for Treatment of Tuberculosis?-Reference-Cited by-同舟云学术

Are We Moving Towards Development of Universal Drug Regimen for Treatment of Tuberculosis?

Published:2022-11-07 Issue:1 Volume:62 Page:5-7
ISSN:0377-9343
Container-title:The Indian Journal of Chest Diseases and Allied Sciences
language:en
Short-container-title:

Author:

Prasad Rajendra,Gupta Nikhil,Singh Abhijeet

Publisher

Jaypee Brothers Medical Publishing

Subject

General Medicine

Link

https://www.ijcdas.com/doi/pdf/10.5005/ijcdas-62-1-5

Reference19 articles.

1. 1. World Health Organization. Global Tuberculosis Report 2019. Geneva: WHO; 2019 (WHO/CDS/TB/2019.15). Available at URL: https://www.who.int/tb/publications/global_report/en/. Accessed on: December 15, 2019.

2. 2. Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias HM, et al. WHO's new end TB strategy. Lancet 2015;385:1799–1801.

3. 3. Revised National Tuberculosis Control Programme. New Delhi, India: RNTCP; 2017. Central TB Division, Ministry of Health and Family Welfare, Government of India. National Strategic Plan for Tuberculosis Elimination 2017-2025. (Draft) Available at URL: http://www.tbcindia.gov.in/WriteReadData/NSP%20Draft%20 20.02.2017%201.pdf. Accessed on: December 16, 2019.

4. 4. World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis, 2016 update (October 2016 revision). (WHO/HTM/TB/2016.04). WHO, Geneva, 2016. Available at URL: https://apps.who.int/iris/bitstre am/10665/250125/1/9789241549639-eng.pdf. Accessed on: December 15, 2019.

5. 5. World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis treatment. WHO, Geneva, 2019 (WHO/CDS/TB/2019.7); Available at URL: https://www.who.int/tb/.../consolidated guidelines-drug-resistant-TB-treatment/en/. Accessed on: December 22, 2019.